Research / DVLT / Fundamental state Inspectable configuration
State dimensions Filing 0001104659-21-036564 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
27.79% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 50th Own-history percentile · N=8
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.16% · OPTIONAL · VALID
Operating cash generation 100th Own-history percentile · N=9
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-410.11% · OPTIONAL · VALID
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
44.30% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure 10th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
112.65% · OPTIONAL · VALID
Gross margin 100th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.gross_margin
17.76% · CORE · VALID
Operating margin 100th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.operating_margin
-469.51% · CORE · VALID
R&D intensity 0th Own-history percentile · N=10
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
190.18% · OPTIONAL · VALID
SBC intensity 70th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
39.85% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 33 states Self-history eligible
Sep 30, 2021 8/9 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 8/8 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 127.84%
Current 27.79%
Delta -100.05% Capex Intensity Increased
Previous 0.82%
Current 2.16%
Delta 1.34% Cash Generation Increased
Previous -439.37%
Current -410.11%
Delta 29.27% Growth Decreased
Previous 44.87%
Current 44.30%
Delta -0.57% Inventory Pressure Decreased
Previous 424.38%
Current 112.65%
Delta -311.74% Margin Increased
Previous 17.13%
Current 17.76%
Delta 0.63% Profitability Increased
Previous -491.76%
Current -469.51%
Delta 22.25% R And D Intensity Decreased
Previous 204.28%
Current 190.18%
Delta -14.10% Sbc Intensity Decreased
Previous 109.06%
Current 39.85%
Delta -69.21% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.